Moral decision-making in patients with neurodegenerative diseases: a systematic review.
Research
Frontiers in psychology
Feb. 12, 2026
Mitophagy bridges glucose metabolism, inflammation and neuroprotection in astrocytes.
Research
Autophagy
Feb. 12, 2026
Baseline Regional Cholinergic Denervation Predicts Cognitive Trajectories in Moderate Parkinson Disease.
Research
Annals of clinical and translational neurology
Feb. 12, 2026
MSN Templated with L-Dopa Amide Derivatives Outperforms the Efficiency of Free-L-Dopa in Reducing Parkinson's Behavioral Dysfunction in Mice.
Research
International journal of nanomedicine
Feb. 12, 2026
DASH Diet, Triglycerides and AIP in Parkinson's Disease
Trial
N/A
Completed
Feb. 11, 2026
Clinical Validity of the DANU Sports System for Gait and Balance Assessment in Parkinson's Disease
Trial
N/A
Recruiting
Feb. 11, 2026
Objective Mobility Assessment Using Wearable Technology for Clinical Application in Parkinson's Disease: From Validation to Fall Prediction
Trial
N/A
Recruiting
Feb. 11, 2026
Effects of Magnetic Stimulation of the Dorsal Spinal Cord on Gait in Patients With ParkinsonĀ“s Disease and Deep Brain Stimulation
Trial
N/A
Completed
Feb. 11, 2026
Differential Neural Substrates of Freezing of Gait in Cerebral Small Vessel Disease and Parkinson Disease: A Dual-tracer PET Study.
Research
Clinical nuclear medicine
Feb. 11, 2026
Miquelianin and spiraeoside from Filipendula ulmaria mitigate Ī±-synuclein accumulation in C.elegans and reduce the expression of neuroinflammatory cytokines in human microglia.
Research
Frontiers in pharmacology
Feb. 11, 2026
Colonic Tissue Biopsy Detection of Phosphorylated Alpha-synuclein for Parkinson's Diagnosis or REM Sleep Behavior Disorder
Trial
N/A
Recruiting
Feb. 10, 2026
Optimistic and Pessimistic Dopamine Signals in the Human Brain: a Mapping and Modelling Study in Health and Parkinson's Disease
Trial
N/A
Recruiting
Feb. 10, 2026
Intranasal Insulin in Parkinson's Disease
Trial
Phase 2
Completed
Feb. 10, 2026
Colonoscopic Detection of Phosphorylated Alpha-synuclein for Parkinson's Diagnosis
Trial
N/A
Recruiting
Feb. 10, 2026
Italian Translation and Validation of the GIDS-PD Scale for Parkinson's Disease
Trial
N/A
Recruiting
Feb. 10, 2026
Quantification of Phosphorylated Alpha-synuclein in Cutaneous Biopsies as a Prospective Biomarker in Parkinson's Disease
Trial
N/A
Active, not recruiting
Feb. 10, 2026
Stereotactic Intracerebral Injection of Allogenic IPSC-DAPs in Patients With Parkinson's Disease
Trial
Phase 1
Not yet recruiting
Feb. 10, 2026
Increased risk of incident dementia associated with vitamin D deficiency in glaucoma patients: a TriNetX cohort study.
Research
Frontiers in nutrition
Feb. 10, 2026
Bridging global diversity gaps in Parkinson disease research.
Research
Nature reviews. Neurology
Feb. 10, 2026